Scheduled versus Pro Re Nata Dosing in the VIEW Trials. 27/06/2016
Richard G, Monés J, Wolf S, Korobelnik JF, Guymer R, Goldstein M, Norenberg C, Sandbrink R, Zeitz O. Ophthalmology. 2015 Dec;122(12):2497-503. doi: 10.1016/j.ophtha.2015.08.014. Epub 2015 Oct 21. http://www.ncbi.nlm.nih.gov/pubmed/26477840